Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes

PLoS Pathog. 2021 Feb 18;17(2):e1009306. doi: 10.1371/journal.ppat.1009306. eCollection 2021 Feb.

Authors

Ilja L Kruglikov¹, Philipp E Scherer^{2

3}

Affiliations

¹ Scientific Department, Wellcomet GmbH, Karlsruhe, Germany.
² Touchstone Diabetes Center, Department of Internal Medicine, Dallas, Texas, United States of America.
³ Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

COVID-19 / complications
COVID-19 / physiopathology*
Disease Susceptibility
Endotoxemia / complications*
Humans
Lipopolysaccharides / blood*
Severity of Illness Index

Substances

Lipopolysaccharides

Grants and funding